- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, January 13, 2017
Coverage of our peer-reviewed research in the healthcare and mainstream press.
In an editorial for Modern Healthcare, Merrill Goozner discussed how the GOP’s replacement of Obamacare could prove “disastrous.” He cited an American Journal of Managed Care® (AJMC®) study to show the impact high-deductible health plans could have on public health. The 2013 study, “Medication Utilization and Adherence in a Health Savings Account-Eligible Plan,” found lower rates of treatment adherence among enrollees with hypertension, dyslipidemia, depression, and diabetes in these plans, which often have high deductibles.
Real Money, part of the financial news site TheStreet, featured an article about trends in MannKind (MNKD) stock after Sanofi dropped its inhaled insulin drug Afrezza, advising readers to see an article by Mary Caffrey in Evidence-Based Diabetes Management™ for more information. “The upside of Caffrey’s excellent piece is the downside for MNKD stock,” author Jim Collins wrote. “A dedicated group of diabetics love Afrezza, but are having to fight with their endocrinologists and/or insurance companies to get prescriptions for it.”
Garey Noritz, MD, discussed his research on improving care for a population of children with complex medical needs through care coordination in an interview with RevCycleIntelligence.com. The article states the Noritz’s research did not focus on the direct impact of care coordinators on healthcare costs and quality, instead referencing an AJMC® study, “The Ingredients of Success in a Medicare Accountable Care Organization.” The authors of that research found that nurse care coordinators in 1 accountable care organization helped to identify and minimize wasteful spending.”
Research Points to Potential MCIDs in Diabetes Distress Scale–17
November 29th 2023Researchers identified a value of at least 0.25 to be a minimal clinically important difference (MCID) in diabetes distress, and MCID values of 0.38 and 0.39 for emotional and interpersonal distress subscales and physician and regimen distress subscales, respectively.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Balancing Care Access and Fragmentation for Better Outcomes in Veterans With Diabetes
April 22nd 2021The authors of a study in the April 2021 issue of The American Journal of Managed Care® discuss the possible reasons behind the link between care fragmentation and hospitalizations in veterans with diabetes, as well as potential opportunities to address disjointed care in the context of the widespread telehealth uptake seen during the COVID-19 pandemic.
Listen
